Kelvin988 personal page - To The Moon

Kelvin988

Kelvin988

No personal profile

2Follow

10Followers

0Topic

0Badge

2021-07-07

?

Sorry, the original content has been removed

2021-07-02

$Exela Technologies, Inc.(XELA)$no eye see

2021-06-10

Hah

"New Stock News" Keji Pharmaceutical (02171. HK) will introduce 9 investors including Eli Lilly in its IPO next Monday

2021-06-10

Kelvin

"New Stock News" rumors that mainland chain Chinese medicine clinic Gushengtang plans to go public in Hong Kong this year to raise US $300-400 million

2021-06-10

Hahahahahaha

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3586416125812919","uuid":"3586416125812919","gmtCreate":1623322661149,"gmtModify":1623404527384,"name":"Kelvin988","pinyin":"kelvin988","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/25cdf1b8f4e8f392e7110577c7a7fb02","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":10,"headSize":2,"tweetSize":62,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.07.20","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.64%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":140880505,"gmtCreate":1625646126507,"gmtModify":1703745554271,"author":{"id":"3586416125812919","authorId":"3586416125812919","name":"Kelvin988","avatar":"https://static.tigerbbs.com/25cdf1b8f4e8f392e7110577c7a7fb02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586416125812919","idStr":"3586416125812919"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/140880505","repostId":"1158311385","repostType":4,"isVote":1,"tweetType":1,"viewCount":2603,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":156144381,"gmtCreate":1625205806043,"gmtModify":1703738347588,"author":{"id":"3586416125812919","authorId":"3586416125812919","name":"Kelvin988","avatar":"https://static.tigerbbs.com/25cdf1b8f4e8f392e7110577c7a7fb02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586416125812919","idStr":"3586416125812919"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>no eye see","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>no eye see","text":"$Exela Technologies, Inc.(XELA)$no eye see","images":[{"img":"https://static.tigerbbs.com/518943a749efb46dab3017aa3dcb1edd","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156144381","isVote":1,"tweetType":1,"viewCount":2241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":183859675,"gmtCreate":1623323433597,"gmtModify":1704200871660,"author":{"id":"3586416125812919","authorId":"3586416125812919","name":"Kelvin988","avatar":"https://static.tigerbbs.com/25cdf1b8f4e8f392e7110577c7a7fb02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586416125812919","idStr":"3586416125812919"},"themes":[],"htmlText":"Hah&nbsp;","listText":"Hah&nbsp;","text":"Hah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183859675","repostId":"2140408437","repostType":4,"repost":{"id":"2140408437","kind":"news","pubTimestamp":1622800499,"share":"https://ttm.financial/m/news/2140408437?lang=en_US&edition=fundamental","pubTime":"2021-06-04 17:54","market":"us","language":"zh","title":"\"New Stock News\" Keji Pharmaceutical (02171. HK) will introduce 9 investors including Eli Lilly in its IPO next Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2140408437","media":"AAFN","summary":"内地生物制药公司科济药业公布招股详细，计划发行9,474.7万股，当中10%为本地发售，90%为国际配售，每股招股价介乎29.6至32.8元，集资最多约31.07亿元。每手500股入场费约16,565.26元，联席保荐人为高盛及瑞银。招股期由下周一起至下周四结束，料於6月18日上市。是次招股共引入9名基石投资者，包括礼来亚洲基金、新华人寿、CloudAlpha、睿远、WT基金、广发证券、Dymon Asia、常春藤及南方基金，合共认购约17.85亿元或2.3亿美元等值股份，设6个月禁售期。","content":"<p><html><body>Keji Pharmaceutical (02171. HK), a mainland biopharmaceutical company, announced the details of its IPO. It plans to issue 94.747 million shares, of which 10% will be sold locally and 90% will be placed internationally. The IPO price per share ranges from 29.6 to 32.8 yuan, raising up to about 3.107 billion yuan. The admission fee for each lot of 500 shares is approximately 16,565.26 yuan, and the joint sponsors are<a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a>(b)<a href=\"https://laohu8.com/S/UBS\">UBS</a>。 The IPO period starts next Monday (7th) and ends next Thursday (10th), and is expected to be listed on June 18th. A total of 9 cornerstone investors were introduced to this IPO, including<a href=\"https://laohu8.com/S/LLY\">Eli Lilly</a>Asia Fund, Xinhua Life Insurance, CloudAlpha, Ruiyuan, WT Fund,<a href=\"https://laohu8.com/S/000776\">GF Securities</a>, Dymon Asia, Ivy and Southern Asset Management, subscribed for a total of approximately 1.785 billion yuan or US $230 million equivalent shares, with a 6-month lock-up period. Xie Lan, senior vice president of finance, said that since the company has not yet commercialized its products, it has recorded operating losses in the past few years. Last year's loss reached 1.064 billion yuan. It is expected to submit a new drug listing application in China for the core product CT053 in the first half of next year. Asked about popular new stocks<a href=\"https://laohu8.com/S/06699\">Angel of the Times</a>(06699. HK) collision period, Li Zonghai, chairman of the board of directors, CEO and chief scientific officer, said that every company has its own characteristics, and investors have different focuses. He also pointed out that the products under research have shown efficacy and safety in clinical trials, and I believe it will be recognized by the market. (gc/a) ~ Aastock Financial News Website: www.aastocks.com</p><p></body></html></p>","source":"aastocks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>\"New Stock News\" Keji Pharmaceutical (02171. HK) will introduce 9 investors including Eli Lilly in its IPO next Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n\"New Stock News\" Keji Pharmaceutical (02171. HK) will introduce 9 investors including Eli Lilly in its IPO next Monday\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">AAFN</strong><span class=\"h-time small\">2021-06-04 17:54</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body>Keji Pharmaceutical (02171. HK), a mainland biopharmaceutical company, announced the details of its IPO. It plans to issue 94.747 million shares, of which 10% will be sold locally and 90% will be placed internationally. The IPO price per share ranges from 29.6 to 32.8 yuan, raising up to about 3.107 billion yuan. The admission fee for each lot of 500 shares is approximately 16,565.26 yuan, and the joint sponsors are<a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a>(b)<a href=\"https://laohu8.com/S/UBS\">UBS</a>。 The IPO period starts next Monday (7th) and ends next Thursday (10th), and is expected to be listed on June 18th. A total of 9 cornerstone investors were introduced to this IPO, including<a href=\"https://laohu8.com/S/LLY\">Eli Lilly</a>Asia Fund, Xinhua Life Insurance, CloudAlpha, Ruiyuan, WT Fund,<a href=\"https://laohu8.com/S/000776\">GF Securities</a>, Dymon Asia, Ivy and Southern Asset Management, subscribed for a total of approximately 1.785 billion yuan or US $230 million equivalent shares, with a 6-month lock-up period. Xie Lan, senior vice president of finance, said that since the company has not yet commercialized its products, it has recorded operating losses in the past few years. Last year's loss reached 1.064 billion yuan. It is expected to submit a new drug listing application in China for the core product CT053 in the first half of next year. Asked about popular new stocks<a href=\"https://laohu8.com/S/06699\">Angel of the Times</a>(06699. HK) collision period, Li Zonghai, chairman of the board of directors, CEO and chief scientific officer, said that every company has its own characteristics, and investors have different focuses. He also pointed out that the products under research have shown efficacy and safety in clinical trials, and I believe it will be recognized by the market. (gc/a) ~ Aastock Financial News Website: www.aastocks.com</p><p></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1103479&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">AAFN</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/8484c32aa045a32d4ca87a47aef4e825","relate_stocks":{"02171":"科济药业-B"},"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1103479&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_english":false,"share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","article_id":"2140408437","content_text":"内地生物制药公司科济药业(02171.HK)公布招股详细，计划发行9,474.7万股，当中10%为本地发售，90%为国际配售，每股招股价介乎29.6至32.8元，集资最多约31.07亿元。每手500股入场费约16,565.26元，联席保荐人为高盛及瑞银。招股期由下周一(7日)起至下周四(10日)结束，料於6月18日上市。是次招股共引入9名基石投资者，包括礼来亚洲基金、新华人寿、CloudAlpha、睿远、WT基金、广发证券、Dymon Asia、常春藤及南方基金，合共认购约17.85亿元或2.3亿美元等值股份，设6个月禁售期。财务高级副总裁谢岚表示，由於公司尚未有产品商业化，因此过往几年录得经营亏损，去年度亏损达10.64亿元人民币，料於明年上半年就核心产品CT053提交中国新药上市申请。问到与热门新股时代天使(06699.HK)撞期，董事会主席、首席执行官兼首席科学官李宗海称，每家公司都有特点，投资者亦有不同关注重点，又指在研产品於临床实验中显示出有疗效及安全性，相信会得到市场认可。(gc/a)~阿思达克财经新闻网址: www.aastocks.com","news_type":1,"symbols_score_info":{"02171":0.9}},"isVote":1,"tweetType":1,"viewCount":2203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183850225,"gmtCreate":1623323383167,"gmtModify":1704200870680,"author":{"id":"3586416125812919","authorId":"3586416125812919","name":"Kelvin988","avatar":"https://static.tigerbbs.com/25cdf1b8f4e8f392e7110577c7a7fb02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586416125812919","idStr":"3586416125812919"},"themes":[],"htmlText":"Kelvin&nbsp;","listText":"Kelvin&nbsp;","text":"Kelvin","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183850225","repostId":"2141651312","repostType":4,"repost":{"id":"2141651312","kind":"news","pubTimestamp":1623146294,"share":"https://ttm.financial/m/news/2141651312?lang=en_US&edition=fundamental","pubTime":"2021-06-08 17:58","market":"us","language":"zh","title":"\"New Stock News\" rumors that mainland chain Chinese medicine clinic Gushengtang plans to go public in Hong Kong this year to raise US $300-400 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2141651312","media":"AAFN","summary":"据路透旗下《IFR》报道，内地连锁中医诊所固生堂计划今年来港上市，筹3-4亿美元。公司股东包括中国平安  、中国人寿  及斯道(Eight Roads)等。公司在北京、广州、深圳及佛山等地经营34所诊所。据官网介绍，固生堂中医集传统中医医疗、传统中医教学、中医推广等为一体，总部设在广州，平台服务覆盖全国56个城市。(el/u) ~阿思达克财经新闻网址: www.aastocks.com","content":"<p><html><body>According to Reuters's \"IFR\" report, Gushengtang, a mainland chain Chinese medicine clinic, plans to go public in Hong Kong this year and raise US $300-400 million. Company shareholders include<a href=\"https://laohu8.com/S/601318\">China Ping An</a>、<a href=\"https://laohu8.com/S/LFC\">China Life Insurance</a>And Eight Roads, etc. The company operates 34 clinics in Beijing, Guangzhou, Shenzhen and Foshan. According to official website, Gushengtang Traditional Chinese Medicine integrates traditional Chinese medicine medical treatment, traditional Chinese medicine teaching and traditional Chinese medicine promotion. It is headquartered in Guangzhou, and its platform services cover 56 cities across the country. (el/u) ~ Aastock Financial News Website: www.aastocks.com</p><p></body></html></p>","source":"aastocks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>\"New Stock News\" rumors that mainland chain Chinese medicine clinic Gushengtang plans to go public in Hong Kong this year to raise US $300-400 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n\"New Stock News\" rumors that mainland chain Chinese medicine clinic Gushengtang plans to go public in Hong Kong this year to raise US $300-400 million\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">AAFN</strong><span class=\"h-time small\">2021-06-08 17:58</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body>According to Reuters's \"IFR\" report, Gushengtang, a mainland chain Chinese medicine clinic, plans to go public in Hong Kong this year and raise US $300-400 million. Company shareholders include<a href=\"https://laohu8.com/S/601318\">China Ping An</a>、<a href=\"https://laohu8.com/S/LFC\">China Life Insurance</a>And Eight Roads, etc. The company operates 34 clinics in Beijing, Guangzhou, Shenzhen and Foshan. According to official website, Gushengtang Traditional Chinese Medicine integrates traditional Chinese medicine medical treatment, traditional Chinese medicine teaching and traditional Chinese medicine promotion. It is headquartered in Guangzhou, and its platform services cover 56 cities across the country. (el/u) ~ Aastock Financial News Website: www.aastocks.com</p><p></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1104136&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">AAFN</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","relate_stocks":{"02628":"中国人寿","00388":"香港交易所","02318":"中国平安","02273":"固生堂"},"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1104136&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_english":false,"share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","article_id":"2141651312","content_text":"据路透旗下《IFR》报道，内地连锁中医诊所固生堂计划今年来港上市，筹3-4亿美元。公司股东包括中国平安  、中国人寿  及斯道(Eight Roads)等。公司在北京、广州、深圳及佛山等地经营34所诊所。据官网介绍，固生堂中医集传统中医医疗、传统中医教学、中医推广等为一体，总部设在广州，平台服务覆盖全国56个城市。(el/u) ~阿思达克财经新闻网址: www.aastocks.com","news_type":1,"symbols_score_info":{"02628":0.9,"02273":0.9,"00388":0.6,"02318":0.6}},"isVote":1,"tweetType":1,"viewCount":2271,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183824477,"gmtCreate":1623323265999,"gmtModify":1704200868900,"author":{"id":"3586416125812919","authorId":"3586416125812919","name":"Kelvin988","avatar":"https://static.tigerbbs.com/25cdf1b8f4e8f392e7110577c7a7fb02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586416125812919","idStr":"3586416125812919"},"themes":[],"htmlText":"Hahahahahaha","listText":"Hahahahahaha","text":"Hahahahahaha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183824477","isVote":1,"tweetType":1,"viewCount":2304,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":156144381,"gmtCreate":1625205806043,"gmtModify":1703738347588,"author":{"id":"3586416125812919","authorId":"3586416125812919","name":"Kelvin988","avatar":"https://static.tigerbbs.com/25cdf1b8f4e8f392e7110577c7a7fb02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586416125812919","authorIdStr":"3586416125812919"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>no eye see","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>no eye see","text":"$Exela Technologies, Inc.(XELA)$no eye see","images":[{"img":"https://static.tigerbbs.com/518943a749efb46dab3017aa3dcb1edd","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156144381","isVote":1,"tweetType":1,"viewCount":2241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":140880505,"gmtCreate":1625646126507,"gmtModify":1703745554271,"author":{"id":"3586416125812919","authorId":"3586416125812919","name":"Kelvin988","avatar":"https://static.tigerbbs.com/25cdf1b8f4e8f392e7110577c7a7fb02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586416125812919","authorIdStr":"3586416125812919"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/140880505","repostId":"1158311385","repostType":4,"repost":{"id":"1158311385","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1625645708,"share":"https://ttm.financial/m/news/1158311385?lang=en_US&edition=fundamental","pubTime":"2021-07-07 16:15","market":"hk","language":"zh","title":"Tiger Black Market: Conoya-B rose more than 12%, Landsea Green Life rose more than 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1158311385","media":"老虎资讯综合","summary":"7月7日消息，康诺亚-B暗盘报60.5港元，较发行价涨12.66%，公司每股定价53.3港元，每手500股；朗诗绿色生活暗盘报3.4港元，较发行价涨14.45%，随后涨幅进一步扩大，截至发稿，暴涨10","content":"<p>News on July 7,<a href=\"https://laohu8.com/S/02162\">Connoa-B</a>The black market quoted HK $60.5, an increase of 12.66% from the issue price. The company priced HK $53.3 per share, with 500 shares per lot;<a href=\"https://laohu8.com/S/01965\">Landsea Green Living</a>The black market quoted HK $3.4, an increase of 14.45% from the issue price, and then the increase further expanded. As of press time, it soared 107% to HK $6.6. The company priced HK $3.18 per share, with 1,000 shares per lot. Both new stocks will be listed on the Hong Kong stock market on July 8 (Thursday).</p><p><img src=\"https://static.tigerbbs.com/1e7024f78c771b2eb45815906863af39\" tg-width=\"1080\" tg-height=\"2337\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/bb479025a974a33d56dbab0afe5c3660\" tg-width=\"1080\" tg-height=\"2337\" referrerpolicy=\"no-referrer\"></p><p>In the previous public subscription stage of Conoya-B, a total of 249,663 people subscribed for it, and 37,046 people won the lottery. The winning rate of one lot was 6.5%, and the oversubscription was 429.97 times. The relevant data of Tiger Information Collation is as follows:</p><p><img src=\"https://static.tigerbbs.com/ffe520ea4c4648301be1073719bc59d2\" tg-width=\"1059\" tg-height=\"824\" referrerpolicy=\"no-referrer\"></p><p>In the previous public subscription stage of Landsea Green Life, a total of 20,236 people subscribed, and 4,438 people won the lottery. The winning rate of one lot was 18%, and the oversubscription was 8.01 times. The relevant data of Tiger Information Collation is as follows:</p><p><img src=\"https://static.tigerbbs.com/df2d623bf4c29673d7455f65fb43fca6\" tg-width=\"1059\" tg-height=\"824\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tiger Black Market: Conoya-B rose more than 12%, Landsea Green Life rose more than 14%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTiger Black Market: Conoya-B rose more than 12%, Landsea Green Life rose more than 14%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time smaller\">2021-07-07 16:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>News on July 7,<a href=\"https://laohu8.com/S/02162\">Connoa-B</a>The black market quoted HK $60.5, an increase of 12.66% from the issue price. The company priced HK $53.3 per share, with 500 shares per lot;<a href=\"https://laohu8.com/S/01965\">Landsea Green Living</a>The black market quoted HK $3.4, an increase of 14.45% from the issue price, and then the increase further expanded. As of press time, it soared 107% to HK $6.6. The company priced HK $3.18 per share, with 1,000 shares per lot. Both new stocks will be listed on the Hong Kong stock market on July 8 (Thursday).</p><p><img src=\"https://static.tigerbbs.com/1e7024f78c771b2eb45815906863af39\" tg-width=\"1080\" tg-height=\"2337\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/bb479025a974a33d56dbab0afe5c3660\" tg-width=\"1080\" tg-height=\"2337\" referrerpolicy=\"no-referrer\"></p><p>In the previous public subscription stage of Conoya-B, a total of 249,663 people subscribed for it, and 37,046 people won the lottery. The winning rate of one lot was 6.5%, and the oversubscription was 429.97 times. The relevant data of Tiger Information Collation is as follows:</p><p><img src=\"https://static.tigerbbs.com/ffe520ea4c4648301be1073719bc59d2\" tg-width=\"1059\" tg-height=\"824\" referrerpolicy=\"no-referrer\"></p><p>In the previous public subscription stage of Landsea Green Life, a total of 20,236 people subscribed, and 4,438 people won the lottery. The winning rate of one lot was 18%, and the oversubscription was 8.01 times. The relevant data of Tiger Information Collation is as follows:</p><p><img src=\"https://static.tigerbbs.com/df2d623bf4c29673d7455f65fb43fca6\" tg-width=\"1059\" tg-height=\"824\" referrerpolicy=\"no-referrer\"></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","relate_stocks":{"01965":"朗诗绿色生活","02162":"康诺亚-B"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158311385","content_text":"7月7日消息，康诺亚-B暗盘报60.5港元，较发行价涨12.66%，公司每股定价53.3港元，每手500股；朗诗绿色生活暗盘报3.4港元，较发行价涨14.45%，随后涨幅进一步扩大，截至发稿，暴涨107%，报6.6港元，公司每股定价3.18港元，每手1000股。两只新股均将于7月8日（周四）港股上市。\n\n康诺亚-B在此前的公开认购阶段，共有249663人申购，中签人数37046人，一手中签率6.5%，超额认购429.97倍。老虎资讯整理相关数据如下表：\n\n朗诗绿色生活在此前的公开认购阶段，共有20236人申购，中签人数4438人，一手中签率18%，超额认购8.01倍。老虎资讯整理相关数据如下表：","news_type":1,"symbols_score_info":{"01965":0.9,"02162":0.9}},"isVote":1,"tweetType":1,"viewCount":2603,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183859675,"gmtCreate":1623323433597,"gmtModify":1704200871660,"author":{"id":"3586416125812919","authorId":"3586416125812919","name":"Kelvin988","avatar":"https://static.tigerbbs.com/25cdf1b8f4e8f392e7110577c7a7fb02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586416125812919","authorIdStr":"3586416125812919"},"themes":[],"htmlText":"Hah&nbsp;","listText":"Hah&nbsp;","text":"Hah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183859675","repostId":"2140408437","repostType":4,"repost":{"id":"2140408437","kind":"news","pubTimestamp":1622800499,"share":"https://ttm.financial/m/news/2140408437?lang=en_US&edition=fundamental","pubTime":"2021-06-04 17:54","market":"us","language":"zh","title":"\"New Stock News\" Keji Pharmaceutical (02171. HK) will introduce 9 investors including Eli Lilly in its IPO next Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2140408437","media":"AAFN","summary":"内地生物制药公司科济药业公布招股详细，计划发行9,474.7万股，当中10%为本地发售，90%为国际配售，每股招股价介乎29.6至32.8元，集资最多约31.07亿元。每手500股入场费约16,565.26元，联席保荐人为高盛及瑞银。招股期由下周一起至下周四结束，料於6月18日上市。是次招股共引入9名基石投资者，包括礼来亚洲基金、新华人寿、CloudAlpha、睿远、WT基金、广发证券、Dymon Asia、常春藤及南方基金，合共认购约17.85亿元或2.3亿美元等值股份，设6个月禁售期。","content":"<p><html><body>Keji Pharmaceutical (02171. HK), a mainland biopharmaceutical company, announced the details of its IPO. It plans to issue 94.747 million shares, of which 10% will be sold locally and 90% will be placed internationally. The IPO price per share ranges from 29.6 to 32.8 yuan, raising up to about 3.107 billion yuan. The admission fee for each lot of 500 shares is approximately 16,565.26 yuan, and the joint sponsors are<a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a>(b)<a href=\"https://laohu8.com/S/UBS\">UBS</a>。 The IPO period starts next Monday (7th) and ends next Thursday (10th), and is expected to be listed on June 18th. A total of 9 cornerstone investors were introduced to this IPO, including<a href=\"https://laohu8.com/S/LLY\">Eli Lilly</a>Asia Fund, Xinhua Life Insurance, CloudAlpha, Ruiyuan, WT Fund,<a href=\"https://laohu8.com/S/000776\">GF Securities</a>, Dymon Asia, Ivy and Southern Asset Management, subscribed for a total of approximately 1.785 billion yuan or US $230 million equivalent shares, with a 6-month lock-up period. Xie Lan, senior vice president of finance, said that since the company has not yet commercialized its products, it has recorded operating losses in the past few years. Last year's loss reached 1.064 billion yuan. It is expected to submit a new drug listing application in China for the core product CT053 in the first half of next year. Asked about popular new stocks<a href=\"https://laohu8.com/S/06699\">Angel of the Times</a>(06699. HK) collision period, Li Zonghai, chairman of the board of directors, CEO and chief scientific officer, said that every company has its own characteristics, and investors have different focuses. He also pointed out that the products under research have shown efficacy and safety in clinical trials, and I believe it will be recognized by the market. (gc/a) ~ Aastock Financial News Website: www.aastocks.com</p><p></body></html></p>","source":"aastocks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>\"New Stock News\" Keji Pharmaceutical (02171. HK) will introduce 9 investors including Eli Lilly in its IPO next Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n\"New Stock News\" Keji Pharmaceutical (02171. HK) will introduce 9 investors including Eli Lilly in its IPO next Monday\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">AAFN</strong><span class=\"h-time small\">2021-06-04 17:54</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body>Keji Pharmaceutical (02171. HK), a mainland biopharmaceutical company, announced the details of its IPO. It plans to issue 94.747 million shares, of which 10% will be sold locally and 90% will be placed internationally. The IPO price per share ranges from 29.6 to 32.8 yuan, raising up to about 3.107 billion yuan. The admission fee for each lot of 500 shares is approximately 16,565.26 yuan, and the joint sponsors are<a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a>(b)<a href=\"https://laohu8.com/S/UBS\">UBS</a>。 The IPO period starts next Monday (7th) and ends next Thursday (10th), and is expected to be listed on June 18th. A total of 9 cornerstone investors were introduced to this IPO, including<a href=\"https://laohu8.com/S/LLY\">Eli Lilly</a>Asia Fund, Xinhua Life Insurance, CloudAlpha, Ruiyuan, WT Fund,<a href=\"https://laohu8.com/S/000776\">GF Securities</a>, Dymon Asia, Ivy and Southern Asset Management, subscribed for a total of approximately 1.785 billion yuan or US $230 million equivalent shares, with a 6-month lock-up period. Xie Lan, senior vice president of finance, said that since the company has not yet commercialized its products, it has recorded operating losses in the past few years. Last year's loss reached 1.064 billion yuan. It is expected to submit a new drug listing application in China for the core product CT053 in the first half of next year. Asked about popular new stocks<a href=\"https://laohu8.com/S/06699\">Angel of the Times</a>(06699. HK) collision period, Li Zonghai, chairman of the board of directors, CEO and chief scientific officer, said that every company has its own characteristics, and investors have different focuses. He also pointed out that the products under research have shown efficacy and safety in clinical trials, and I believe it will be recognized by the market. (gc/a) ~ Aastock Financial News Website: www.aastocks.com</p><p></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1103479&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">AAFN</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/8484c32aa045a32d4ca87a47aef4e825","relate_stocks":{"02171":"科济药业-B"},"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1103479&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_english":false,"share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","article_id":"2140408437","content_text":"内地生物制药公司科济药业(02171.HK)公布招股详细，计划发行9,474.7万股，当中10%为本地发售，90%为国际配售，每股招股价介乎29.6至32.8元，集资最多约31.07亿元。每手500股入场费约16,565.26元，联席保荐人为高盛及瑞银。招股期由下周一(7日)起至下周四(10日)结束，料於6月18日上市。是次招股共引入9名基石投资者，包括礼来亚洲基金、新华人寿、CloudAlpha、睿远、WT基金、广发证券、Dymon Asia、常春藤及南方基金，合共认购约17.85亿元或2.3亿美元等值股份，设6个月禁售期。财务高级副总裁谢岚表示，由於公司尚未有产品商业化，因此过往几年录得经营亏损，去年度亏损达10.64亿元人民币，料於明年上半年就核心产品CT053提交中国新药上市申请。问到与热门新股时代天使(06699.HK)撞期，董事会主席、首席执行官兼首席科学官李宗海称，每家公司都有特点，投资者亦有不同关注重点，又指在研产品於临床实验中显示出有疗效及安全性，相信会得到市场认可。(gc/a)~阿思达克财经新闻网址: www.aastocks.com","news_type":1,"symbols_score_info":{"02171":0.9}},"isVote":1,"tweetType":1,"viewCount":2203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183850225,"gmtCreate":1623323383167,"gmtModify":1704200870680,"author":{"id":"3586416125812919","authorId":"3586416125812919","name":"Kelvin988","avatar":"https://static.tigerbbs.com/25cdf1b8f4e8f392e7110577c7a7fb02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586416125812919","authorIdStr":"3586416125812919"},"themes":[],"htmlText":"Kelvin&nbsp;","listText":"Kelvin&nbsp;","text":"Kelvin","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183850225","repostId":"2141651312","repostType":4,"isVote":1,"tweetType":1,"viewCount":2271,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183824477,"gmtCreate":1623323265999,"gmtModify":1704200868900,"author":{"id":"3586416125812919","authorId":"3586416125812919","name":"Kelvin988","avatar":"https://static.tigerbbs.com/25cdf1b8f4e8f392e7110577c7a7fb02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586416125812919","authorIdStr":"3586416125812919"},"themes":[],"htmlText":"Hahahahahaha","listText":"Hahahahahaha","text":"Hahahahahaha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183824477","isVote":1,"tweetType":1,"viewCount":2304,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}